Research study of an investigational medication for moderate-to-severe eczema given together with common vaccinations
Study Details
Study Id: CA43-SFY17915
Age: 18+
Delivery Method: Injection
Study Length: 36 Weeks
Compensation: May be available for qualified participants.
In this research study we are evaluating an investigational eczema medication to see how it may affect common vaccinations, and how well and safely it works when given with those vaccines.
There is no cost to participate. Qualified participants will have regular visits with study doctors who specialize in treating atopic dermatitis.
Participation will last about 36 weeks and involve about 7 visits to the study research site.
Participants who satisfy applicable requirements may be reimbursed for study-related expenses (e.g. meal(s) and transportation/parking).
Qualifications for study participation include:
- Must be 18 years of age or above
- Must have eczema affecting at least 10% of the skin surface
- Must have had unsatisfactory symptom improvement from, or been unable to tolerate, eczema treatment in the past 6 months.
Fill out this form or call our clinical trial line 289-763-8666 to discuss if this trial is right for you.
- 105-5 Quarry Ridge Rd. Barrie, On, L4M 7G1
© 2024 SimcoDerm